Hospira recalls solution marked as heparin

Hospira ($HSP), whose shareholders agreed this week to a $15 billion buyout from Pfizer ($PFE), has yet another class I recall in the works. The Lake Forest, IL-based drugmaker is voluntarily recalling 181,704 bags of magnesium sulfate in 5% dextrose injections because labels on the immediate container may have barcodes indicating that it is instead the blood thinner heparin. Recall notice | More

Suggested Articles

McCallum was hit with a warning letter from the FDA for testing issues with its products and failing to keep appropriate records.

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.